Relay Therapeutics Inc (RLAY)
4.75
+0.11
(+2.37%)
USD |
NASDAQ |
Nov 22, 16:00
4.74
-0.01
(-0.21%)
Pre-Market: 20:00
Relay Therapeutics Total Assets (Quarterly): 930.12M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 930.12M |
| June 30, 2024 | 772.55M |
| March 31, 2024 | 841.44M |
| December 31, 2023 | 843.98M |
| September 30, 2023 | 906.96M |
| June 30, 2023 | 962.02M |
| March 31, 2023 | 1.038B |
| December 31, 2022 | 1.100B |
| September 30, 2022 | 1.169B |
| June 30, 2022 | 889.42M |
| Date | Value |
|---|---|
| March 31, 2022 | 949.88M |
| December 31, 2021 | 1.008B |
| September 30, 2021 | 671.62M |
| June 30, 2021 | 714.40M |
| March 31, 2021 | 771.35M |
| December 31, 2020 | 799.83M |
| September 30, 2020 | 751.68M |
| June 30, 2020 | 348.04M |
| March 31, 2020 | 370.27M |
| December 31, 2019 | 393.07M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
348.04M
Minimum
Jun 2020
1.169B
Maximum
Sep 2022
811.56M
Average
842.71M
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc | 219.48B |
| Summit Therapeutics Inc | 502.85M |
| Biomarin Pharmaceutical Inc | 6.851B |
| Lexicon Pharmaceuticals Inc | 321.12M |
| Arbutus Biopharma Corp | 140.44M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 91.25M |
| Shareholders Equity (Quarterly) | 838.86M |